Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retisert in Diabetic Macular Edema
NCT00502541Phase 3Completed
- Sponsor
- Bausch + Lomb
- Start
- Sep 2001
- Primary completion
- Sep 2006
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of fluocinolone acetonide in diabetic macular edema (DME), sponsored by Bausch + Lomb. Started Sep 2001; status: completed.
02
Drugs
fluocinolone acetonide
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT00502541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00502541.